Harkant Singh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Harkant Singh has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Ganesh Kasinadhuni
Department of Cardiology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
2 shared publications - Rajesh Vijayvergiya
Department of Cardiology, Post Graduate Institute of Medical Education & Research, Chandigarh, India
2 shared publications - Vivek Jaswal
Department of Cardiothoracic and Vascular Surgery Post Graduate Institute of Medical Education and Research Chandigarh India
2 shared publications Aduri Raja S Dutta
Department of Cardiothoracic Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, IND
1 shared publication- Ajay Bahl
Department of Cardiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
1 shared publication - Ajay Savlania
Department of General Surgery, Post Graduate Institute of Medical Education and Research, Chandigarh, India
1 shared publication
Latest Publications
- 7 September 2024
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 87 (2) , 395-398
Projectile Ballistic Injury to the Right Chest: A Life-Threatening Complication of a Firecracker
- 7 September 2024
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 87 (2) , 395-398
Projectile Ballistic Injury to the Right Chest: A Life-Threatening Complication of a Firecracker
- Open Access
- 15 September 2023
- Published by Springer Nature in Cureus
- Vol. 15 (9) , e45304
Early and Mid-Term Outcomes of Primary Repair After Atrioventricular Canal Defect: A Single-Center Eight-Year Experience
Background/aim: Surgical repair techniques and management of patients with atrioventricular septal defect (AVSD) have progressed over the last few decades. Early and definitive interventions have become the choice of treatment for these patients. Based on this background, we aimed to review the early and mid-term outcomes of primary AVSD repair. Methods: A total of 53 patients with a mean age of 3.45 ± 5.67 years underwent definitive repair for AVSD between January 2014 and June 2021. The clinical data including age, type of defect, associated co-anomalies, symptoms, pulmonary hypertension, etc. were collected and assessed retrospectively. Mitral regurgitation (MR) as a clinical outcome was assessed at 0, 1, 2, and 5 years. Results: Among the recruited patients, 35 (66.1%) were male and 18 (33.9%) were female. Of 53 patients, repair for the complete defect was done in 38 (71.69%) patients, repair for intermediate/partial defect was done in 15 (23.1%) patients, and one patient underwent repair for incomplete type. Other associated co-anomalies were anterior mitral leaflet (12 (22.6%)), atrial and ventricular septal defect (VSD) (30 (56.6%)), and patent ductus arteriosus (PDA) (11 (20.8%)). Different procedures for surgical repair included patch closure, cleft repair, and polytetrafluoroethylene (PTFE) VSD closure. After repair, the mean follow-up period was 46.73 ± 27.37 months. Overall mortality was 3.78% (2/53), and two patients underwent reintervention due to symptomatic severe MR. Conclusions: A definitive and timely correction of AVSD shows satisfactory early and mid-term results.
- 15 September 2023
- Published by Springer Nature in Cureus
- Vol. 15 (9) , e45304
Open AccessEarly and Mid-Term Outcomes of Primary Repair After Atrioventricular Canal Defect: A Single-Center Eight-Year Experience
Background/aim: Surgical repair techniques and management of patients with atrioventricular septal defect (AVSD) have progressed over the last few decades. Early and definitive interventions have become the choice of treatment for these patients. Based on this background, we aimed to review the early and mid-term outcomes of primary AVSD repair. Methods: A total of 53 patients with a mean age of 3.45 ± 5.67 years underwent definitive repair for AVSD between January 2014 and June 2021. The clinical data including age, type of defect, associated co-anomalies, symptoms, pulmonary hypertension, etc. were collected and assessed retrospectively. Mitral regurgitation (MR) as a clinical outcome was assessed at 0, 1, 2, and 5 years. Results: Among the recruited patients, 35 (66.1%) were male and 18 (33.9%) were female. Of 53 patients, repair for the complete defect was done in 38 (71.69%) patients, repair for intermediate/partial defect was done in 15 (23.1%) patients, and one patient underwent repair for incomplete type. Other associated co-anomalies were anterior mitral leaflet (12 (22.6%)), atrial and ventricular septal defect (VSD) (30 (56.6%)), and patent ductus arteriosus (PDA) (11 (20.8%)). Different procedures for surgical repair included patch closure, cleft repair, and polytetrafluoroethylene (PTFE) VSD closure. After repair, the mean follow-up period was 46.73 ± 27.37 months. Overall mortality was 3.78% (2/53), and two patients underwent reintervention due to symptomatic severe MR. Conclusions: A definitive and timely correction of AVSD shows satisfactory early and mid-term results.
- Open Access
- 19 November 2021
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 25 (11) , 829-831
Percutaneous suture based device closure of an inadvertent right ventricle perforation following pericardiocentesis
- 19 November 2021
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 25 (11) , 829-831
Open AccessPercutaneous suture based device closure of an inadvertent right ventricle perforation following pericardiocentesis
- Open Access
- 1 October 2020
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 34 (10) , 2823-2826
Left Atrial Dissection and Rupture Following Excision of Left Atrial Myxoma: Role of Transesophageal Echocardiography
- 1 October 2020
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 34 (10) , 2823-2826
Open AccessLeft Atrial Dissection and Rupture Following Excision of Left Atrial Myxoma: Role of Transesophageal Echocardiography
- Open Access
- 9 September 2020
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 4 (5) , 1-6
Thoracic endovascular aortic repair in management of aorto-oesophageal fistulas: a case series
Background : Aorto-oesophageal fistula (AOF) is a rare, catastrophic disease with an extremely poor prognosis. A ruptured thoracic aortic aneurysm is a common aetiology for AOF. The clinical presentation is usually massive haematemesis and collapse. Timely diagnosis and appropriate treatment are crucial in managing AOF.Case summary : We hereby report two cases of AOF, who underwent successful emergency thoracic endovascular aortic repair (TEVAR) to control active bleed and exsanguination. Case 1, an elderly lady with atherosclerotic aneurysm had TEVAR followed by open surgery for oesophageal rent and necrosed left main bronchus. Case 2 had mycotic tubercular aneurysm who later had infected graft-stent following TEVAR.Discussion : Open surgery is the conventional treatment for AOF; however, TEVAR can be an alternative and less invasive approach in selected high-risk patients. Various management issues related to TEVAR with AOF have been discussed in the article.
- 9 September 2020
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 4 (5) , 1-6
Open AccessThoracic endovascular aortic repair in management of aorto-oesophageal fistulas: a case series
Background : Aorto-oesophageal fistula (AOF) is a rare, catastrophic disease with an extremely poor prognosis. A ruptured thoracic aortic aneurysm is a common aetiology for AOF. The clinical presentation is usually massive haematemesis and collapse. Timely diagnosis and appropriate treatment are crucial in managing AOF.Case summary : We hereby report two cases of AOF, who underwent successful emergency thoracic endovascular aortic repair (TEVAR) to control active bleed and exsanguination. Case 1, an elderly lady with atherosclerotic aneurysm had TEVAR followed by open surgery for oesophageal rent and necrosed left main bronchus. Case 2 had mycotic tubercular aneurysm who later had infected graft-stent following TEVAR.Discussion : Open surgery is the conventional treatment for AOF; however, TEVAR can be an alternative and less invasive approach in selected high-risk patients. Various management issues related to TEVAR with AOF have been discussed in the article.
- Open Access
- 1 September 2018
- Published by Springer Nature in Journal of the Egyptian Society of Cardio-Thoracic Surgery
- Vol. 26 (3) , 228-230
Large intrapulmonary solitary fibrous tumor of right lower lobe
- 1 September 2018
- Published by Springer Nature in Journal of the Egyptian Society of Cardio-Thoracic Surgery
- Vol. 26 (3) , 228-230
Open AccessLarge intrapulmonary solitary fibrous tumor of right lower lobe
- Open Access
- 1 September 2018
- Published by Springer Nature in Journal of the Egyptian Society of Cardio-Thoracic Surgery
- Vol. 26 (3) , 163-170
Echocardiographic study of functional tricuspid regurgitation and results of tricuspid valve repair
- 1 September 2018
- Published by Springer Nature in Journal of the Egyptian Society of Cardio-Thoracic Surgery
- Vol. 26 (3) , 163-170
Open AccessEchocardiographic study of functional tricuspid regurgitation and results of tricuspid valve repair
- 27 February 2018
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 34 (4) , 488-490
Congenital cystic adenomatoid malformation of the lung in adults: report of two cases and review of the literature
Congenital cystic adenomatoid malformation (CCAM) is characterized by adenomatoid proliferation of bronchiole-like structures and cysts formation. It isan uncommon cause of respiratory distress in infants. Most common presentation is in first two years of life with complaints of respiratory distress.Presentation in adulthood is rare. Surgical intervention is the mainstay treatment.We describe two cases of atypical CCAM presenting in adulthood with past history of tuberculosis. To our knowledge only one case of CCAM with tuberculosis has been reported in literature.
- 27 February 2018
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 34 (4) , 488-490
Congenital cystic adenomatoid malformation of the lung in adults: report of two cases and review of the literature
Congenital cystic adenomatoid malformation (CCAM) is characterized by adenomatoid proliferation of bronchiole-like structures and cysts formation. It isan uncommon cause of respiratory distress in infants. Most common presentation is in first two years of life with complaints of respiratory distress.Presentation in adulthood is rare. Surgical intervention is the mainstay treatment.We describe two cases of atypical CCAM presenting in adulthood with past history of tuberculosis. To our knowledge only one case of CCAM with tuberculosis has been reported in literature.
- Open Access
- 1 January 2018
- Published by Federation of Turkish Pathology Societies in Turkish Journal of Pathology
- Vol. 35 (1) , 15-21
Proliferation marker (ki67) in sub-categorization of neuroendocrine tumours of the lung
The 2015 WHO classification classifies neuroendocrine tumours (NET) of the lung into typical carcinoid, atypical carcinoid, large cell neuroendocrine carcinoma and small cell carcinoma based on morphology alone. Mitosis is the major parameter for this classification, and thus several studies have focused on the role of Ki67 in these tumours but without conclusive results. The aim of the study was to categorize neuroendocrine tumours of the lung based on morphology and to assess the utility of Ki67 in diagnosis. The study included 42 cases (23 biopsies and 19 lobectomy specimens) of neuroendocrine tumours (excluding small cell carcinoma). Haematoxylin & eosin stained sections, immunohistochemistry for neuroendocrine markers and Ki67 were studied. Based on WHO criteria, cases were classified as typical carcinoids (83.3%), atypical carcinoids (12%) and large cell neuroendocrine carcinomas (4.7%). The Ki67 index ranged between 1%-10% (mean 2.6%), 10%-30% (mean 19%), 35%-50% (mean 42.5%) in typical carcinoid, atypical carcinoid and large cell neuroendocrine carcinoma respectively. Using the ROC curve, the cut off value of Ki67 for typical and atypical carcinoids was 7.5% (P value < 0.001), and for atypical carcinoid/large cell neuroendocrine carcinoma was 32.5% (P value=0.051). On comparing the size and infiltration pattern (both local and lymphovascular invasion) of tumours in resected specimens, there was no association with the proliferation index (P value > 0.05). Morphological features are the gold standard for subtyping of neuroendocrine tumours. Ki-67 is a potentially meaningful marker for sub-categorization of lung NETs, especially in small biopsies. However, the size and infiltrative pattern of the tumours are independent of the proliferation index.
- 1 January 2018
- Published by Federation of Turkish Pathology Societies in Turkish Journal of Pathology
- Vol. 35 (1) , 15-21
Open AccessProliferation marker (ki67) in sub-categorization of neuroendocrine tumours of the lung
The 2015 WHO classification classifies neuroendocrine tumours (NET) of the lung into typical carcinoid, atypical carcinoid, large cell neuroendocrine carcinoma and small cell carcinoma based on morphology alone. Mitosis is the major parameter for this classification, and thus several studies have focused on the role of Ki67 in these tumours but without conclusive results. The aim of the study was to categorize neuroendocrine tumours of the lung based on morphology and to assess the utility of Ki67 in diagnosis. The study included 42 cases (23 biopsies and 19 lobectomy specimens) of neuroendocrine tumours (excluding small cell carcinoma). Haematoxylin & eosin stained sections, immunohistochemistry for neuroendocrine markers and Ki67 were studied. Based on WHO criteria, cases were classified as typical carcinoids (83.3%), atypical carcinoids (12%) and large cell neuroendocrine carcinomas (4.7%). The Ki67 index ranged between 1%-10% (mean 2.6%), 10%-30% (mean 19%), 35%-50% (mean 42.5%) in typical carcinoid, atypical carcinoid and large cell neuroendocrine carcinoma respectively. Using the ROC curve, the cut off value of Ki67 for typical and atypical carcinoids was 7.5% (P value < 0.001), and for atypical carcinoid/large cell neuroendocrine carcinoma was 32.5% (P value=0.051). On comparing the size and infiltration pattern (both local and lymphovascular invasion) of tumours in resected specimens, there was no association with the proliferation index (P value > 0.05). Morphological features are the gold standard for subtyping of neuroendocrine tumours. Ki-67 is a potentially meaningful marker for sub-categorization of lung NETs, especially in small biopsies. However, the size and infiltrative pattern of the tumours are independent of the proliferation index.
- Open Access
- 18 October 2012
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 42 (5) , 901
Solitary pericardial hydatid cyst encompassing the heart
A 56-year old lady presented with mild chest pain. The echocardiography revealed gross pericardial effusion. Repeated percutaneous aspirations were performed. Ultimately, computed tomography helped in reaching the diagnosis of pericardial hydatid disease (Fig. 1A). On operating, a single infected cyst was found encompassing the heart with multiple daughter cysts (Figs 1B and 2A–C).
- 18 October 2012
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 42 (5) , 901
Open AccessSolitary pericardial hydatid cyst encompassing the heart
A 56-year old lady presented with mild chest pain. The echocardiography revealed gross pericardial effusion. Repeated percutaneous aspirations were performed. Ultimately, computed tomography helped in reaching the diagnosis of pericardial hydatid disease (Fig. 1A). On operating, a single infected cyst was found encompassing the heart with multiple daughter cysts (Figs 1B and 2A–C).